Abstract:Background Inflammatory arthritis (IA) is a group of autoimmune arthritis characterized by a pro-inflammatory/anti-inflammatory disbalance of local mediators[1][2]. Research on the influence of gut microbiota(GM) on systemic IA has exploded in the past decade. GM changes may be a crucial regulatory component in systemic IA[3]. However, the link between them has yet to be fully elucidated. Objectives This study aims to study the GM composition of IA to provide evidence for its potential role in the pathogenesis, progress, and treatment of IA. Methods We systematically searched the trials for PubMed, EMBASE, Web of Science, Medline, Wanfang database, VIP, CNKI, and CBM database from the establishment of the database to January 1, 2023. Standardized mean difference (SMD) and 95% confidence interval (CI) were calculated to assess alterations in α-diversity and the abundance of certain microbiota families in IA. Literature quality was evaluated according to the requirements of systematic review, and meta-analysis was performed using STATA v.12.0. Results A total of 70 studies, including 3,322 patients and 4,412 healthy controls, were identified. Compared with HCs, the GM of patients with IA has a lower Simpson index(SMD=-0.307, 95%CI -0.509, -0.106) and Shannon index(SMD=-0.184, 95%CI -0.344, -0.024). When specific IA was examined, significant decreases were observed in rheumatoid arthritis(Simpson index: SMD=-0.558, 95%CI -0.891, -0.225; Shannon index: SMD=-0.608, 95%CI -0.935, -0.281; ACE: SMD=-0.414, 95%CI -0.697, -0.132; Chao1: SMD= -1.373, 95%CI -1.980, -0.766; eveness index: SMD=-1.863, 95%CI -3.181, -0.544), psoriatic arthritis(Simpson index: SMD=-0.733, 95%CI -1.367, -0.099), osteoarthritis(Chao1: SMD=-0.793, 95%CI -1.096, -0.491) and gout(Simpson index: SMD=-1.037, 95%CI -1.959, -0.115). In other diseases, we found that the α-diversity index was higher than that of the HCs group[reactive arthritis(Shannon index: SMD=0.697, 95%CI 0.265, 1.130; ACE: SMD=1.878, 95%CI 1.375, 2.380; Chao1:SMD=0.835, 95%CI 0.398, 1.273; InvSimpson: SMD=0.823, 95%CI 0.386, 1.260; Observed species: SMD= 2.004, 95%CI 1.491, 2.517); osteoporosis(eveness index: SMD=0.488, 95%CI 0.047, 0.928); ankylosing spondylitis(InvSimpson: SMD=0.525, 95%CI 0.272, 0.777); Juvenile idiopathic arthritis(Observed species: SMD=1.672, 95%CI 1.100, 2.243)]. Furthermore, to exclude sequencing methods’ influence on species abundance detection, we conducted a subgroup analysis of Observed species. The results showed that the observed species abundance through high-throughput sequencing was higher(SMD=1.376, 95%CI 0.394, 2.358) and 16S rRNA gene sequencing was lower(SMD=-0.842, 95%CI -1.575, -0.108) than that of HC. At the phylum level, there was a significant reduction in Firmicutes(SMD=-0.455, 95%CI -0.796, -0.114) and Fusobacteria(SMD=-0.422, 95%CI -0.692, -0.152). At the genus level, the abundance of Bacteroides(SMD=0.898, 95%CI 0.003, 0.003) was higher and Faecalibacterium(SMD=-0.380, 95%CI -0.713, -0.047) was lower. The two groups had no significant differences in Bifidobacterium and Butyricicoccus(P >0.05). Conclusion Our research showed a definite relationship between IA and GM. Further diet and drug therapy research are needed to explore the relationship between human GM and IA. References [1]Nikiphorou, E., Lempp, H. & Kohrt, B. A. Treatment failure in inflammatory arthritis: time to think about syndemics? Rheumatology (Oxford) 58, 1526-1533, doi:10.1093/rheumatology/kez222 (2019). [2]Bañuls-Mirete, M., Ogdie, A. & Guma, M. Micronutrients: Essential Treatment for Inflammatory Arthritis? Curr Rheumatol Rep 22, 87, doi:10.1007/s11926-020-00962-z (2020). [3]Li, B. et al. Microbiota-assisted therapy for systemic inflammatory arthritis: advances and mechanistic insights. Cell Mol Life Sci 79, 470, doi:10.1007/s00018-022-04498-6 (2022). Acknowledgements: NIL. Disclosure of Interests None Declared.

Association of low-grade inflammation caused by gut microbiota disturbances with osteoarthritis: A systematic review

Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics

"Cross-talk" between gut microbiome dysbiosis and osteoarthritis progression: a systematic review

The Gut Microbiome and Joint Microbiome Show Alterations in Patients With Knee Osteoarthritis Versus Controls: A Systematic Review

The gut microbiota in osteoarthritis: where do we stand and what can we do?

Gut permeability and osteoarthritis, towards a mechanistic understanding of the pathogenesis: a systematic review

Altered gut microbiome profile in patients with knee osteoarthritis

The Complex Interplay between the Gut Microbiome and Osteoarthritis: A Systematic Review on Potential Correlations and Therapeutic Approaches

The gut microbiome-joint connection: implications in osteoarthritis

The causal role of gut microbiota in development of osteoarthritis

Gut-microbiota modulation: The impact of thegut-microbiotaon osteoarthritis

Gut microbiota and obesity-associated osteoarthritis

The immune role of the intestinal microbiome in knee osteoarthritis: a review of the possible mechanisms and therapies

The effects and significance of gut microbiota and its metabolites on the regulation of osteoarthritis: Close coordination of gut-bone axis

Ab0001 gut microbiota imbalance in inflammatory arthritis: a systematic review and meta-analysis

Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model

The Gut-Joint Axis in Osteoarthritis

Dysbiosis of the Gut Microbiome is a Risk Factor for Osteoarthritis in Older Female Adults: a Case Control Study

Potential efficacy of gut microbiome dysbiosis on alleviation the progress of osteoarthritis in mice

Gut microbiota changes in patients with spondyloarthritis: A systematic review

The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature